Bladder cancer is among the ten most common cancers globally, causes considerable
morbidity and mortality and is, therefore, a substantial burden for health-care systems. The …

Bladder cancer (BCa) is the most common malignancy of the urinary tract and one of the
most prevalent cancers worldwide. While the clinical approach to BCa has remained largely …

Abstract Background The European Association of Urology (EAU) prognostic factor risk
groups for non–muscle-invasive bladder cancer (NMIBC) are used to provide …

Bladder cancer (BC) is a leading cause of death among urothelial malignancies that more
commonly affect male population. Poor prognosis and resistance to chemotherapy are the …

Objective The aim of this study was to summarize and analyze the current evidence
regarding the prognostic and predictive value of preoperative neutrophil-to-lymphocyte ratio …

Background Several groups have proposed features to identify low-risk patients who may
benefit from endoscopic kidney-sparing surgery in upper tract urothelial carcinoma (UTUC) …

Bladder cancer tumors can be divided into two molecular subtypes referred to as luminal or
basal. Each subtype may react differently to current chemotherapy or immunotherapy …

Bladder cancer (BC) is a common malignancy associated with high morbidity and mortality,
however, accurate and convenient risk assessment tools applicable to BC patients are …

Purpose To evaluate the prognostic value of substaging on oncological outcomes in patients
with T (or pT1) urothelial carcinoma of the bladder. Methods A literature search using …

Background: The most common bladder cancer (BC) histotype is pure urothelial carcinoma
(UC), which may undergo divergent differentiation in some cases. Variant histology (VH) …